Researcher.Life Logo

Saudi Pharmaceutical Journal : Impact Factor & More

eISSN: 2213-7475pISSN: 1319-0164
JournalOpen Access

Key Metrics

CiteScore
6.8
Impact Factor
< 5
SJR
Q2Pharmacology
SNIP
1.53
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Saudi Pharmaceutical Journal

Saudi Pharmaceutical Journal Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher ELSEVIER
Language English
Frequency Bi-monthly
Article Processing ChargesUSD 1450
Publication Time12
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
Society/Institute/SponsorKing Saud University
FrequencyBi-monthly
Publication Start Year1993
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 12
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Saudi Pharmaceutical Journal ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Saudi Pharmaceutical Journal

Molecular mechanisms attributed to colistin renal proximal tubular epithelial cytotoxicity
  • 24 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Targeting triple-negative breast cancer: apoptotic and antitumor effects of Artemisia sieberi Besser extracts
  • 24 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Impact of coverage of drug availability regulations across the supply chain cycle in Saudi Arabia
  • 17 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis.
  • 12 Nov 2025
  • Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Effects of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and nonalcoholic fatty liver disease: A cohort study
  • 27 Oct 2025
  • Saudi Pharmaceutical Journal : SPJ
Acidifying agents impact erlotinib and gefitinib pharmacokinetic parameters and elevate liver enzymes in Wistar rats
  • 1 Oct 2025
  • Saudi Pharmaceutical Journal : SPJ
Molecular mechanisms attributed to colistin renal proximal tubular epithelial cytotoxicity
  • 24 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Targeting triple-negative breast cancer: apoptotic and antitumor effects of Artemisia sieberi Besser extracts
  • 24 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Impact of coverage of drug availability regulations across the supply chain cycle in Saudi Arabia
  • 17 Nov 2025
  • Saudi Pharmaceutical Journal : SPJ
Current status and trends of anti-tumor biosimilars in China from 2019 to 2023: A cross-sectional analysis.
  • 12 Nov 2025
  • Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
Effects of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes and nonalcoholic fatty liver disease: A cohort study
  • 27 Oct 2025
  • Saudi Pharmaceutical Journal : SPJ
Acidifying agents impact erlotinib and gefitinib pharmacokinetic parameters and elevate liver enzymes in Wistar rats
  • 1 Oct 2025
  • Saudi Pharmaceutical Journal : SPJ

FAQs on Saudi Pharmaceutical Journal